MPS Pharma Ltd. - Research Center
531686 ADVIKLA Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | - | - | 0.03 | - | - |
| Expenses | |||||
| Material consumed | - | 0.04 | 0.05 | - | - |
| Manufacturing expenses | 0.05 | 0.05 | 0.05 | 0.06 | 0.05 |
| Personnel expenses | 0.53 | 0.49 | 0.42 | 0.40 | 0.45 |
| Selling expenses | - | 0.01 | 0.01 | 0.01 | 0.01 |
| Adminstrative expenses | 0.22 | 0.36 | 0.18 | 3.66 | 0.17 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 0.80 | 0.95 | 0.71 | 4.13 | 0.68 |
| Operating profit | -0.80 | -0.95 | -0.68 | -4.13 | -0.67 |
| Other recurring income | 0.09 | 0.02 | 0.26 | 0.20 | 0.01 |
| Adjusted PBDIT | -0.71 | -0.92 | -0.42 | -3.94 | -0.66 |
| Financial expenses | - | - | - | - | - |
| Depreciation | 0.15 | 0.15 | 0.51 | 0.56 | 0.57 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | -0.85 | -1.07 | -0.93 | -4.49 | -1.24 |
| Tax charges | -0.02 | -0.02 | -0.79 | -0.08 | -0.07 |
| Adjusted PAT | -0.83 | -1.05 | -0.14 | -4.42 | -1.17 |
| Non recurring items | - | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | -0.83 | -1.05 | -0.14 | -4.42 | -1.17 |
| Earnigs before appropriation | -17.24 | -16.41 | -15.35 | -15.21 | -10.79 |
| Equity dividend | - | - | - | - | - |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | -17.24 | -16.41 | -15.35 | -15.21 | -10.79 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis